Approval · Notice of Compliance 36512 · 2025
FLUTREXIN: Notice of Compliance 36512
Issued December 11, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36512
- Date
- December 11, 2025
- Company
- Modern Veterinary Therapeutics LlcSunrise, Florida, United States
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- BANAMINE (Intervet Canada Corp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUTREXIN | 02563584 | Marketed |
Medicinal ingredients
- FLUNIXIN MEGLUMINE 50 MG per ML